top of page
< Back

$1,000,000.00

CA

PAR-25-438

Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)

This funding opportunity invites applications to join the Rare Diseases Clinical Research Network. The goal is to improve how rare diseases are diagnosed, treated, and managed. The research is patient-focused, involves multiple sites working together, and combines laboratory and clinical studies. A big focus is finding people with rare diseases early and making sure they are ready to take part in clinical trials.

Full Description

the objective of this notice of funding opportunity (nofo) is to invite new and renewal applications for the rare diseases clinical research consortia (rdcrc) that comprise the rare diseases clinical research network (rdcrn). the rdcrcs are intended to advance and improve diagnosis, management, and treatment of numerous, rare diseases through highly collaborative, multi-site, patient-centric, translational, and clinical research. special emphasis will be placed on the early and timely identification of individuals with rare diseases and clinical trial readiness.

If you want to feel more confident about your application, we're here. Reach out anytime!

Agency:

Contact:

Deadline:

National Institutes of Health

2025-10-16

bottom of page